Swedbank AB Buys 13,190 Shares of Agilent Technologies, Inc. $A

Key Points

• Swedbank AB increased its stake in Agilent Technologies, Inc. by 8.9%, owning 160,616 shares valued at approximately $18.95 million as of the last quarter.
• Agilent Technologies reported $1.37 earnings per share for the recent quarter, meeting analysts' expectations and achieving a 10.1% year-over-year revenue increase to $1.74 billion.
• The company recently announced a quarterly dividend of $0.248 per share, reflecting an annualized yield of 0.8% and a payout ratio of 23.24%.

Swedbank AB lifted its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 160,616 shares of the medical research company's stock after purchasing an additional 13,190 shares during the period. Swedbank AB owned 0.06% of Agilent Technologies worth $18,954,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies in the 2nd quarter worth about $273,000. Lineweaver Wealth Advisors LLC bought a new stake in Agilent Technologies during the second quarter worth about $448,000. Chesley Taft & Associates LLC grew its holdings in Agilent Technologies by 2.2% in the second quarter. Chesley Taft & Associates LLC now owns 9,304 shares of the medical research company's stock worth $1,098,000 after purchasing an additional 200 shares during the period. Procyon Advisors LLC increased its stake in shares of Agilent Technologies by 8.7% during the second quarter. Procyon Advisors LLC now owns 2,131 shares of the medical research company's stock valued at $251,000 after purchasing an additional 171 shares in the last quarter. Finally, Pallas Capital Advisors LLC purchased a new position in shares of Agilent Technologies during the second quarter valued at approximately $1,984,000.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Agilent Technologies Stock Performance

A traded down $0.25 during trading on Tuesday, reaching $126.08. 340,864 shares of the company were exchanged, compared to its average volume of 1,937,935. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a 50 day moving average of $120.37 and a 200 day moving average of $115.81. The stock has a market cap of $35.74 billion, a P/E ratio of 29.61, a PEG ratio of 3.93 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies's revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. Agilent Technologies's dividend payout ratio (DPR) is 23.24%.

Analyst Ratings Changes

Several brokerages have recently weighed in on A. TD Cowen raised their price target on Agilent Technologies to $150.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Evercore ISI dropped their target price on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research note on Thursday, August 28th. UBS Group reduced their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. JPMorgan Chase & Co. decreased their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a report on Thursday, May 29th. Finally, Wall Street Zen downgraded Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and an average target price of $140.08.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.